Anne Germain, PhD, is the CEO and Founder of NOCTEM Health, a company creating the next generation digital insomnia care solutions. She is a clinical psychologist, a sleep scientist, and a sleep medicine innovator with over 20 years of academic clinical research focused on the treatment and neurobiological underpinnings of nightmares and insomnia in the context of trauma-related psychiatric disorders.
Todd is a registered PSG technologist and is Vice President of Product Development at Dymedix Diagnostics. Todd has worked in clinical sleep medicine for over 35 years and has served as President of the AAST, as well as being active in BRPT exam development for many years. Over the last decade, Todd has been focused on developing physiological sensors for use in testing sleep disorders.
Morgan Moncada is the CEO and Co-Founder of Neru Health and a Harvard Blavatnik Life Science Fellow. As a sleep apnea and insomnia patient, he struggled to get diagnosed and access to care. At Neru, he’s on a mission to make therapy success continuous and effortless for patients and providers in chronic care. Morgan has over a decade of experience commercializing early-stage life science technologies across business development, product operations, and scientific strategy roles.
